Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Growth Hormone
Long-acting growth hormone releasing hormone analog for sustained GH and IGF-1 elevation.
Peptide B
Growth Hormone
Refined ghrelin mimetic — stronger GH release than GHRP-6 with less hunger.
Typical vial
2 mg
Typical dose
100-300 mcg
Half-life
~30 minutes (no DAC) / 6-8 days (with DAC)
FDA status
Not FDA approved for human use.
Typical vial
5 mg
Typical dose
100 mcg
Half-life
~15-60 minutes
FDA status
Not FDA approved for any indication.
CJC-1295 effects
GHRP-2 effects
CJC-1295 side effects
GHRP-2 side effects
CJC-1295 dosing ranges
Anti-aging and recovery (Mod GRF)
100 mcg · Once to three times daily (SubQ) · 8-12 weeks
Body composition (Mod GRF + Ipamorelin)
100-300 mcg · Two to three times daily · 8-12 weeks
CJC-1295 with DAC
1000-2000 mcg · Once or twice weekly · 8-12 weeks
GHRP-2 dosing ranges
GH optimization / anti-aging
100 mcg · Two to three times daily (SubQ) · 8-12 weeks
Combined with CJC-1295 (Mod GRF)
100 mcg of each · Two to three times daily · 8-12 weeks
Adult GHD diagnostic (Japan, clinical)
100 mcg IV bolus · Single dose · One-time test
CJC-1295: Long-acting growth hormone releasing hormone analog for sustained GH and IGF-1 elevation. Typical dose 100-300 mcg. GHRP-2: Refined ghrelin mimetic — stronger GH release than GHRP-6 with less hunger. Typical dose 100 mcg. Both fall under the Growth Hormone category.
Stacking CJC-1295 with GHRP-2 is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
CJC-1295 is typically dosed: Once to three times daily (SubQ) for Anti-aging and recovery (Mod GRF); Two to three times daily for Body composition (Mod GRF + Ipamorelin); Once or twice weekly for CJC-1295 with DAC. GHRP-2 is typically dosed: Two to three times daily (SubQ) for GH optimization / anti-aging; Two to three times daily for Combined with CJC-1295 (Mod GRF); Single dose for Adult GHD diagnostic (Japan, clinical).
CJC-1295: Not FDA approved for human use. GHRP-2: Not FDA approved for any indication.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free